StonvexLoading…
StonvexStonvexStonvexCore line items from PD's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2026 2026-01-31 | Annual 2025 2025-01-31 | Annual 2024 2024-01-31 | Annual 2023 2023-01-31 |
|---|---|---|---|---|
Revenue | $492.55M | $467.50M | $430.70M | $370.79M |
Operating Income | $5.84M | $-59.77M | $-96.25M | $-129.38M |
Net Income | $173.37M | $-42.73M | $-75.19M | $-128.42M |
EPS (Diluted) | $1.87 | $-0.59 | $-0.89 | $-1.45 |
Total Assets | $990.51M | $927.27M | $925.31M | $817.87M |
Total Liabilities | $719.85M | $779.22M | $746.41M | $575.79M |
Cash & Equivalents | $237.40M | $346.46M | $363.01M | $274.02M |
Free Cash Flow OCF − CapEx | $111.92M | $115.10M | $69.81M | $12.34M |
Shares Outstanding | 84.62M | 91.08M | 92.74M | 91.18M |